IPCIQ — Intellipharmaceutics International Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $1.92m
- $3.70m
- $0.07m
Annual cashflow statement for Intellipharmaceutics International, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.7 | -8.08 | -3.39 | -5.15 | -2.89 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.23 | 0.305 | 1.41 | 1.09 | 0.034 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.603 | 0.62 | 1.68 | 1.42 | 1.27 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.5 | -6.66 | 0.112 | -2.46 | -1.39 |
| Capital Expenditures | -0.101 | -0.014 | -0.004 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.029 | 0 | 0.5 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.101 | -0.014 | 0.025 | 0 | 0.5 |
| Financing Cash Flow Items | -2.91 | 0 | 0 | -0.038 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.4 | 0.101 | 0 | 3.03 | 0.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.74 | -6.58 | 0.137 | 0.57 | -0.688 |